Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Advanced Micro Devices | AMD | Nov 22, 2024 | 138.35 | +0.63 |
AdvanSix | ASIX | Nov 22, 2024 | 31.68 | +1.77 |
Advantage Solutions A | ADV | Nov 22, 2024 | 3.60 | +4.65 |
Advent | AVK | Nov 22, 2024 | 11.87 | +0.08 |
Advent Technologies A | ADN | Nov 22, 2024 | 7.30 | -4.07 |
Adverum Biotechnologies | ADVM | Nov 22, 2024 | 6.04 | +5.04 |
AdvisorShares Pure US Cannabis ETF | MSOS | Nov 22, 2024 | 4.45 | -2.63 |
Advisorshares Star Global Buy-Write ETF | VEGA | Nov 22, 2024 | 44.10 | -0.26 |
AECOM | ACM | Nov 22, 2024 | 116.31 | +3.33 |
Aegon N.V ADR | AEG | Nov 22, 2024 | 6.23 | -0.48 |
Aehr Test Systems | AEHR | Nov 22, 2024 | 12.16 | +3.93 |
Aemetis | AMTX | Nov 22, 2024 | 4.03 | -1.47 |
Aeon Biopharma | AEON | Nov 22, 2024 | 0.53 | -5.17 |
AerCap Holdings | AER | Nov 22, 2024 | 98.03 | +0.32 |
Aeries Technology | AERT | Nov 22, 2024 | 1.05 | -8.70 |
Aerospace & Defense Powershares | PPA | Nov 22, 2024 | 121.04 | +1.25 |
Aerovate Therapeutics | AVTE | Nov 22, 2024 | 2.66 | +1.92 |
AeroVironment | AVAV | Nov 22, 2024 | 195.91 | +0.85 |
AerSale | ASLE | Nov 22, 2024 | 6.57 | +2.66 |
AES | AES | Nov 22, 2024 | 13.04 | -1.58 |
Aetherium Acquisition A | GMFI | Nov 22, 2024 | 11.04 | 0.00 |
Aetherium Acquisition Unit | GMFIU | Nov 22, 2024 | 11.10 | 0.00 |
Aethlon Medical | AEMD | Nov 22, 2024 | 0.40 | +4.90 |
Aeva Technologies | AEVA | Nov 22, 2024 | 4.25 | +12.73 |
AEye A | LIDR | Nov 22, 2024 | 0.96 | +4.75 |
Affiliated Managers Group | AMG | Nov 22, 2024 | 187.60 | +0.54 |
Affimed N.V. | AFMD | Nov 22, 2024 | 2.62 | -0.76 |
Affinity Bancshares | AFBI | Nov 22, 2024 | 21.52 | +0.28 |
Affirm A | AFRM | Nov 22, 2024 | 66.55 | +1.23 |
Aflac | AFL | Nov 22, 2024 | 112.39 | +0.59 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.